U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Pseudomonas aeruginosa resistant to imipenem/relebactam: EM 2972704

Identifiers
BioSample: SAMN17616893; Sample name: EM2972704; SRA: SRS8173276
Organism
Pseudomonas aeruginosa
cellular organisms; Bacteria; Pseudomonadati; Pseudomonadota; Gammaproteobacteria; Pseudomonadales; Pseudomonadaceae; Pseudomonas; Pseudomonas aeruginosa group
Package
Pathogen: clinical or host-associated; version 1.0
Attributes
strainEM 2972704
collection date2005
broad-scale environmental contextmissing
local-scale environmental contextmissing
environmental mediummissing
geographic locationMexico
hostHomo sapiens
isolation and growth conditionmissing
latitude and longitude23.6345 N 102.5528 W
number of repliconsmissing
reference for biomaterialmissing
isolation sourcemissing
collected bymissing
host diseasemissing
Specimen Collector's InstitutionEurofins (Lancaster, PA)
Specimen RepositoryEurofins (Lancaster, PA)
Sample Provider PI's InstitutionLouis Stokes Cleveland Veterans Affairs Medical Center
Sample Provider PI's email[email protected]
Description

Investigation into the mechanism of resistance of Pseudomonas aeruginosa clinical isolates to diazabicyclooctane (DBO) inhibitor relebactam (REL) in combination with imipenem (IMI).

BioProject
PRJNA342804 Pseudomonas aeruginosa
Retrieve all samples from this project

Submission
J. Craig Venter Institute, Derrick Fouts; 2021-01-28
Antibiogram
AntibioticResistance phenotypeMeasurement signMeasurementMeasurement unitsLaboratory typing methodLaboratory typing platformVendorLaboratory typing method version or reagentTesting standard
amikacinresistant>32mg/LMICMicroscanBeckman Coulter IncCLSI
aztreonamresistant>16mg/LMICMicroscanBeckman Coulter IncCLSI
cefepimeresistant>16mg/LMICMicroscanBeckman Coulter IncCLSI
cefotaximenot defined>32mg/LMICMicroscanBeckman Coulter IncCLSI
ceftazidimeresistant>16mg/LMICMicroscanBeckman Coulter IncCLSI
ciprofloxacinresistant>2mg/LMICMicroscanBeckman Coulter IncCLSI
meropenemresistant>8mg/LMICMicroscanBeckman Coulter IncCLSI
levofloxacinresistant>4mg/LMICMicroscanBeckman Coulter IncCLSI
gentamicinresistant>8mg/LMICMicroscanBeckman Coulter IncCLSI
piperacillin-tazobactamresistant>64/4mg/LMICMicroscanBeckman Coulter IncCLSI
tobramycinresistant>8mg/LMICMicroscanBeckman Coulter IncCLSI
imipenemresistant==64mg/LMICcation adjusted Mueller-Hinton (MH) agar dilutionCLSI
ceftazidime-avibactamresistant>256/4mg/LMICLiofilchem Inc.MIC Test StripCLSI
meropenem-vaborbactamresistant>256/8mg/LMICLiofilchem Inc.MIC Test StripCLSI
ceftolozane-tazobactamresistant>256/4mg/LMICLiofilchem Inc.MIC Test StripCLSI
colistinresistant==4mg/LMICBiomérieuxE-TestCLSI
imipenem-relebactamresistant==32/4mg/LMICcation adjusted Mueller-Hinton (MH) agar dilutionmissing
Accession:
SAMN17616893
ID:
17616893

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center